These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17145845)

  • 21. Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer.
    Saintigny P; Besse B; Callard P; Vergnaud AC; Czernichow S; Colombat M; Girard P; Validire P; Breau JL; Bernaudin JF; Soria JC
    Clin Cancer Res; 2007 Aug; 13(16):4825-31. PubMed ID: 17699861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondhand smoke exposure, pulmonary function, and cardiovascular mortality.
    Eisner MD; Wang Y; Haight TJ; Balmes J; Hammond SK; Tager IB
    Ann Epidemiol; 2007 May; 17(5):364-73. PubMed ID: 17300955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondhand smoke and health-related quality of life in never smokers: results from the SAPALDIA cohort study 2.
    Bridevaux PO; Cornuz J; Gaspoz JM; Burnand B; Ackermann-Liebrich U; Schindler C; Leuenberger P; Rochat T; Gerbase MW;
    Arch Intern Med; 2007 Dec; 167(22):2516-23. PubMed ID: 18071176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors predicting poor survival after resection of stage IA non-small cell lung cancer.
    Chang MY; Mentzer SJ; Colson YL; Linden PA; Jaklitsch MT; Lipsitz SR; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):850-6. PubMed ID: 17903494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC.
    Muley T; Fetz TH; Dienemann H; Hoffmann H; Herth FJ; Meister M; Ebert W
    Lung Cancer; 2008 Jun; 60(3):408-15. PubMed ID: 18083270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: results of a prospective observational study.
    Dediu M; Crisan E; Radut M; Tarlea A; Median D; Alexandru A; Vremes G; Gal C
    Lung Cancer; 2009 Feb; 63(2):271-6. PubMed ID: 18565617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancer.
    Gu J; Berman D; Lu C; Wistuba II; Roth JA; Frazier M; Spitz MR; Wu X
    Clin Cancer Res; 2006 Dec; 12(24):7329-38. PubMed ID: 17189404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
    van den Hout WB; Kramer GW; Noordijk EM; Leer JW
    J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does anemia affect outcome after lobectomy or pneumonectomy in early stage lung cancer patients who have not received neo-adjuvant treatment?
    Chamogeorgakis T; Anagnostopoulos C; Kostopanagiotou G; Bhora F; Toumpoulis I; Georgiannakis E; Nabong A; Dosios T; Harrison L; Connery C
    Thorac Cardiovasc Surg; 2008 Apr; 56(3):148-53. PubMed ID: 18365973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Directly measured second hand smoke exposure and asthma health outcomes.
    Eisner MD; Klein J; Hammond SK; Koren G; Lactao G; Iribarren C
    Thorax; 2005 Oct; 60(10):814-21. PubMed ID: 16192366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors in resected satellite-nodule T4 non-small cell lung cancer.
    Rao J; Sayeed RA; Tomaszek S; Fischer S; Keshavjee S; Darling GE
    Ann Thorac Surg; 2007 Sep; 84(3):934-8; discussion 939. PubMed ID: 17720402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Stage IB non-small cell lung cancer: impact of the number of lymph nodes examined on survival].
    Cerón J; Peñalver JC; Jordá C; Padilla J
    Arch Bronconeumol; 2009 Feb; 45(2):87-91. PubMed ID: 19232270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early life second-hand smoke exposure and serious infectious morbidity during the first 8 years: evidence from Hong Kong's "Children of 1997" birth cohort.
    Kwok MK; Schooling CM; Ho LM; Leung SS; Mak KH; McGhee SM; Lam TH; Leung GM
    Tob Control; 2008 Aug; 17(4):263-70. PubMed ID: 18505748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone.
    Huang EH; Liao Z; Cox JD; Guerrero TM; Chang JY; Jeter M; Borghero Y; Wei X; Fossella F; Herbst RS; Blumenschein GR; Moran C; Allen PK; Komaki R
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):779-85. PubMed ID: 17418967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examining time intervals between diagnosis and treatment in the management of patients with limited stage small cell lung cancer.
    Berthelet E; Truong PT; Lesperance M; Lim JT; Wai ES; MacNeil MV; Liu M; Joe H; Olivotto IA
    Am J Clin Oncol; 2006 Feb; 29(1):21-6. PubMed ID: 16462498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of survival and disease-free survival in patients with resected N1 non-small cell lung cancer.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2007 Jul; 84(1):182-8; discussion 189-90. PubMed ID: 17588408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.
    Sienel W; Dango S; Kirschbaum A; Cucuruz B; Hörth W; Stremmel C; Passlick B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):728-34. PubMed ID: 18261918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.